QQQ   417.55 (-1.38%)
AAPL   164.95 (-1.25%)
MSFT   401.13 (-0.78%)
META   487.97 (-2.76%)
GOOGL   154.75 (-0.81%)
AMZN   176.23 (-1.67%)
TSLA   149.30 (-0.42%)
NVDA   817.98 (-3.39%)
AMD   148.63 (-4.16%)
NIO   3.83 (-4.25%)
BABA   68.70 (-0.26%)
T   16.35 (+0.12%)
F   12.12 (+0.50%)
MU   107.54 (-3.92%)
GE   149.23 (-2.43%)
CGC   7.95 (+1.53%)
DIS   111.64 (-0.70%)
AMC   3.19 (+9.25%)
PFE   25.82 (+1.69%)
PYPL   61.95 (-0.24%)
XOM   120.16 (+1.38%)
QQQ   417.55 (-1.38%)
AAPL   164.95 (-1.25%)
MSFT   401.13 (-0.78%)
META   487.97 (-2.76%)
GOOGL   154.75 (-0.81%)
AMZN   176.23 (-1.67%)
TSLA   149.30 (-0.42%)
NVDA   817.98 (-3.39%)
AMD   148.63 (-4.16%)
NIO   3.83 (-4.25%)
BABA   68.70 (-0.26%)
T   16.35 (+0.12%)
F   12.12 (+0.50%)
MU   107.54 (-3.92%)
GE   149.23 (-2.43%)
CGC   7.95 (+1.53%)
DIS   111.64 (-0.70%)
AMC   3.19 (+9.25%)
PFE   25.82 (+1.69%)
PYPL   61.95 (-0.24%)
XOM   120.16 (+1.38%)
QQQ   417.55 (-1.38%)
AAPL   164.95 (-1.25%)
MSFT   401.13 (-0.78%)
META   487.97 (-2.76%)
GOOGL   154.75 (-0.81%)
AMZN   176.23 (-1.67%)
TSLA   149.30 (-0.42%)
NVDA   817.98 (-3.39%)
AMD   148.63 (-4.16%)
NIO   3.83 (-4.25%)
BABA   68.70 (-0.26%)
T   16.35 (+0.12%)
F   12.12 (+0.50%)
MU   107.54 (-3.92%)
GE   149.23 (-2.43%)
CGC   7.95 (+1.53%)
DIS   111.64 (-0.70%)
AMC   3.19 (+9.25%)
PFE   25.82 (+1.69%)
PYPL   61.95 (-0.24%)
XOM   120.16 (+1.38%)
QQQ   417.55 (-1.38%)
AAPL   164.95 (-1.25%)
MSFT   401.13 (-0.78%)
META   487.97 (-2.76%)
GOOGL   154.75 (-0.81%)
AMZN   176.23 (-1.67%)
TSLA   149.30 (-0.42%)
NVDA   817.98 (-3.39%)
AMD   148.63 (-4.16%)
NIO   3.83 (-4.25%)
BABA   68.70 (-0.26%)
T   16.35 (+0.12%)
F   12.12 (+0.50%)
MU   107.54 (-3.92%)
GE   149.23 (-2.43%)
CGC   7.95 (+1.53%)
DIS   111.64 (-0.70%)
AMC   3.19 (+9.25%)
PFE   25.82 (+1.69%)
PYPL   61.95 (-0.24%)
XOM   120.16 (+1.38%)
OTCMKTS:LABFF

Laboratorios Farmaceuticos Rovi (LABFF) Stock Price, News & Analysis

C$86.05
0.00 (0.00%)
(As of 04/18/2024 ET)
Today's Range
C$86.05
C$86.05
50-Day Range
C$52.00
C$86.05
52-Week Range
C$86.05
C$86.05
Volume
N/A
Average Volume
1,300 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
LABFF stock logo

About Laboratorios Farmaceuticos Rovi Stock (OTCMKTS:LABFF)

Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa; and hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express, Fibrilin, and Sodium Heparin Rovi. It also provides contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, and sachets. Laboratorios Farmaceuticos Rovi, S.A. was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.

LABFF Stock Price History

LABFF Stock News Headlines

Laboratorios Farmaceuticos Rovi, S.A. (41L.F)
New crypto project uncovers 2,050% in 65 days
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
Laboratorios Farmaceuticos Rovi S.A. (ROVI)
Laboratorios Farmaceuticos Rovi SA ROVI
Laboratorios Richmond SACIF (RICH)
New crypto project uncovers 2,050% in 65 days
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
Laboratorios Farmaceuticos Rovi S.A.
Logista (LOG)
Laboratorios Farmaceuticos Rovi, S.A. (ROVI.MC)
Laboratorios Farmaceuticos ROVI SA
See More Headlines
Receive LABFF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Laboratorios Farmaceuticos Rovi and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:LABFF
CIK
N/A
Fax
N/A
Employees
1,925
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Ivan Lopez-Belmonte Encina
    Second Deputy Chairman & GM of Commercial and Development
  • Mr. Javier Lopez-Belmonte Encina
    First Deputy Chairman, GM of Industrial Operations & CFO
  • Mr. Juan Lopez-Belmonte Encina
    Chairman & CEO
  • Marta Campos Martínez
    Head of Investor Relations
  • Ms. Mercedes Benítez del Castillo Sánchez
    Legal Department Manager
  • Ms. Beatriz Ávila Alcalde
    Sales Manager
  • Ms. Rosario Perucha Pérez
    Marketing Manager
  • Mr. Francisco Javier Angulo García
    Human Resources Manager
  • Mr. Gabriel Nunez Fernandez
    Secretary

LABFF Stock Analysis - Frequently Asked Questions

How have LABFF shares performed in 2024?

Laboratorios Farmaceuticos Rovi's stock was trading at C$52.00 at the start of the year. Since then, LABFF shares have increased by 65.5% and is now trading at C$86.05.
View the best growth stocks for 2024 here
.

Are investors shorting Laboratorios Farmaceuticos Rovi?

Laboratorios Farmaceuticos Rovi saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 400 shares, a drop of 55.6% from the March 15th total of 900 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.
View Laboratorios Farmaceuticos Rovi's Short Interest
.

How do I buy shares of Laboratorios Farmaceuticos Rovi?

Shares of LABFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:LABFF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners